RhAPPcast

Rheumatology Advanced Practice Providers (RhAPP)
  • 5.0（3則評分）
  • 醫學
RhAPPcast

This is the official podcast of Rheumatology Advanced Practice Providers (RhAPP), a non-profit 501c3 organization dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).    Through our peer-to-peer network, we seek to support the integral role APPs play in the rheumatology healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with rheumatic diseases. 

  1. Med. Review Video Module: What is the efficacy of ixekizumab across the GRAPPA & EULAR domains?

    3 天前

    Med. Review Video Module: What is the efficacy of ixekizumab across the GRAPPA & EULAR domains?

    Join Jessica Farrell, PharmD, a clinical pharmacist and board member of RhAPP, as she breaks down the efficacy of ixekizumab across the GRAPPA domains. In this video, she covers the impact of ixekizumab on peripheral arthritis, axial disease, enthesitis, dactylitis, skin, and nail psoriasis, based on the latest clinical trial data. Learn how this treatment can significantly improve various symptoms in patients with psoriatic arthritis.

    7 分鐘
  2. Medication Review Video Module: What is the safety profile of guselkumab in PsO and PsA?

    12月11日

    Medication Review Video Module: What is the safety profile of guselkumab in PsO and PsA?

    Join Cassie Dolecki, a clinical pharmacy specialist in Rheumatology at Allegheny Health Network in Pittsburgh, Pennsylvania, as she discusses the safety profile of guselkumab in treating psoriatic arthritis and psoriasis. Cassie highlights findings from the DISCOVER-2 trial, a phase three study that assessed the efficacy and safety of guselkumab compared to placebo in biologic-naive patients with active psoriatic disease over two years.

    2 分鐘
  3. FAQ: How does axial PsA differ from AS clinically, genetically, and radiographically

    12月4日

    FAQ: How does axial PsA differ from AS clinically, genetically, and radiographically

    Join Kyle George, a physician assistant and member of RhAPP, as he explores the clinical, genetic, and radiographic differences between axial psoriatic arthritis (Axial PsA) and ankylosing spondylitis (AS). In this FAQ session, Kyle provides insights into how these conditions, despite both causing inflammatory spine pain, differ significantly in their presentation and underlying mechanisms.

    3 分鐘

  4. 11月20日

    Journal Club Video Module

    Join Jessica Farrell, a clinical pharmacist at Albany Medical Center's Division of Rheumatology and faculty member at Albany College of Pharmacy and Health Sciences, as she discusses a significant study published in "Rheumatology and Therapy" in August 2023 by Dr. Miscol. The study titled "Six-Month Persistence and Multi-Domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis" presents real-world data from the CorEvitas PsA and SpA registry.

    4 分鐘
  5. RhAPPcast: Navigating the Complexities: IL-17 Inhibitors and IBD Risk

    11月13日

    RhAPPcast: Navigating the Complexities: IL-17 Inhibitors and IBD Risk

    In this episode of RhAPPcast, host Amanda Mixon, PA-C, dives into the complexities of IL-17 inhibitors and their association with inflammatory bowel disease (IBD). Joined by Candace Ryan, a seasoned rheumatology expert, they explore the benefits and risks of IL-17 therapy for rheumatic patients. Tune in to gain insights into current evidence, clinical trials, and best practices for managing these therapies

    31 分鐘

  6. 11月6日

    FAQ: Why is Binding CD64+ Important When Discussing IL23 Directed Therapy

    Join Heather Mambretti, and a member of RhAPP, as she discusses the significance of CD64 positive binding in IL-23 directed therapy. In this video, Heather explains how targeting CD64 positive cells enhances the specificity and efficacy of IL-23 directed treatments, such as guselkumab, by delivering therapeutic agents directly to sites of inflammation.

    4 分鐘

  7. 11月4日

    Journal Club Review Video Module

    Ingrid Pan, PharmD, pediatric clinical pharmacist at Children's Hospital Colorado, reviews an interim analysis of a Phase 1 trial on the safety and efficacy of upadacitinib in pediatric patients with polyarticular-course juvenile idiopathic arthritis (pcJIA). The study, published in Annals of the Rheumatic Diseases, shows promising results, with ACR 30, 50, and 70 response rates at week 12, and significant improvements in disease activity. Ingrid highlights the low rate of serious adverse eve...

    7 分鐘

  8. 11月1日

    Lost Time: The Impact of Delaying Optimal Therapy in RA & SpA Patients Without Disease Control

    In this episode of RhAPPcast, host Amanda Mixon, president of RhAPP, is joined by Jeannette Hart, PA-C, and faculty member of RhAPP, for an insightful discussion on the impact of delaying optimal therapy in patients with rheumatoid arthritis and spondyloarthropathies. They explore common reasons for treatment delays, the consequences on disease progression and quality of life, and offer practical strategies for healthcare providers to ensure timely intervention. Tune in to learn how early, ag...

    21 分鐘
顯示全部 (58)

評分與評論

5
（滿分 5 顆星）
3 則評分

簡介

This is the official podcast of Rheumatology Advanced Practice Providers (RhAPP), a non-profit 501c3 organization dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).    Through our peer-to-peer network, we seek to support the integral role APPs play in the rheumatology healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with rheumatic diseases. 

資訊

  • 創作者
    Rheumatology Advanced Practice Providers (RhAPP)
  • 活躍年代
    2023年 - 2024年
  • 集數
    58
  • 年齡分級
    兒少適宜
  • 版權
    © 2024 RhAPPcast
  • 節目網站
    RhAPPcast

你可能也會喜歡

若要收聽兒少不宜的單集，請登入帳號。

隨時掌握此節目最新消息

登入或註冊後，即可追蹤節目、儲存單集和掌握最新資訊。
選取國家或地區

非洲、中東和印度

亞太地區

歐洲

拉丁美洲與加勒比海地區

美國與加拿大